"The groundwork of all happiness is health." - Leigh Hunt

What is Flumist, the brand new flu vaccine for kids that’s sprayed into their nose?

There are many children. Afraid from getting a needle, and that would prevent them from getting the vaccine that protects them from the flu. lower than One out of four Australian children needs to be vaccinated against influenza in 2025.

Australian families have an alternative choice this winter. A nasal flu vaccine called FluMist will likely be available for the primary time for kids ages 2-17.

Flow Mist has a needle-free alternative. Current influenza vaccine. Nasal flu vaccines are widely utilized in the UK, Europe, Canada and the US.

Recent studies suggest that each injectable and nasal flu vaccines can be found. Parents prefer Nasal vaccines, especially once they are hesitant about vaccination. Thus, the nasal option could increase vaccination coverage in Australia and reduce the spread of flu, not only amongst children but potentially in the broader community.

FluMist will likely be free for certain age groups in some states and territories. It will even be available for a fee at chosen pharmacies and immunization providers.

Here’s what you want to find out about how FluMist works, how effective it’s, and whether or not your child qualifies.

What is different about this vaccine?

Current vaccines All utilized in Australia are injections. They contain specific components of the influenza virus which are unable to duplicate.

FluMist is different. In this a weak A “live” type of the flu strain. This type is often called a vaccine. Live attenuated vaccine. Other examples include MMR (measles, mumps, rubella), chicken pox and rotavirus vaccines.

With FluMist, six of the eight genetic segments within the influenza virus are altered in order that they can not replicate efficiently at normal body temperature. This implies that the virus only replicates within the nose (which happens at lower temperatures) as an alternative of deep contained in the body.

How do nasal sprays work? Are they more efficient?

To administer FluMist, a health skilled sprays a 0.1ml dose of vaccine into each nostril. It is easy, painful and thoroughly tolerated by children, even very young.

Unlike the injected vaccine, the nasal vaccine triggers a protective immune response where the influenza virus enters the body – on the surface of the upper respiratory tract (mucosa), including the nose and throat. So in theory, nasal sprays should work. better in comparison with injections.

quickly study In the late Nineteen Nineties, it was suggested that the vaccine provides excellent protection against influenza in children—and may provide Some protection Against an influenza strain not included within the vaccine.

However, in practice, subsequent studies have shown that live vaccines potentially provide Similar protection For current injectable vaccines.

It was also in America. A problem within the mid-2010s where the live-attenuated vaccine (given as a nasal spray) was not as effective because the injected vaccine. This led to the advice for its use Took it back From 2016 to 2018.

As a result, Changes were made to the technique of vaccine strain selection.

Data from recent seasons show that nasal spray vaccines are actually Just as effective as an injected vaccine. each Reduce the flu Infection as much as 40-60%.

How protected is the nasal flu vaccine?

The vaccine is protected, with unintended effects much like most injectable influenza vaccines.

Nasal flu vaccine has been done. is used Since 2003 within the US, since 2010 in Canada, and since 2011 in Europe. National Childhood Programme Use of nasal vaccines since 2013.

Oh Proportion People can have unintended effects, but these are mild and temporary. finished half Children may have a stuffy or runny nose, and one in ten may have a fever or headache.

People who’ve a severely weakened immune system (weak immune system) or recurrently take aspirin mustn’t use Flu Mist.

If your child is mildly immunosuppressed, has asthma or one other lung disease, talk over with your GP or specialist in regards to the vaccine. Teens who’re pregnant also needs to seek medical advice.

What are the potential advantages?

The primary advantage of the nasal vaccine is to enhance coverage across an age group. Fear of needles Prevent vaccination in children and in settings where needles are a supply barrier.

The UK introduced a school-based vaccine program in 2013. The effect on vaccine coverage, which was very low before 2013; now, Around half Children there receive an annual influenza vaccine.

We know that unvaccinated children are less more likely to be vaccinated. get sick And to do Take time off from school. And Evidence It also suggests that vaccinating this age group may reduce community transmission of influenza, thereby protecting others.

within the UK, study The introduction of an influenza vaccine for school-aged children is really helpful to scale back GP presentations with influenza in all age groups.

Influenza is predicted to diminish consequently of reducing community transmission. Influenza cases, lower health care costsand reduced pressure on hospitals and healthcare providers.

So, who can get the nasal flu vaccine?

In 2026, FluMist will likely be one in all several influenza vaccines. Available in Australia.. But funding arrangements vary amongst states and territories, affecting who qualifies free of charge vaccines. Others can pay around $50-70.

Nasal vaccine will likely be available from early April. available I:

  • New South Wales And South Australia Available as a state-funded program (free) for kids ages 2–4 and within the private market (for about $50–70) for kids ages 5–17.

  • Queensland As a state-funded program for kids aged 2-5 and privately for people aged 6-17.

  • Western Australia As a state-funded program for kids aged 2–11 (inclusive), and within the private marketplace for those aged 12–17.

  • Australian Capital Territory, Northern Territory, Tasmania and Victoria within the private market for kids aged 2-17 years.

The nasal vaccine is currently only registered for kids in Australia.